Other Aliphatic rings

• 

  N-(oxolan-3-yl)hydroxylamine hydrochloride

  AD1636081803585-56-990%
• 

  3-(aminooxy)cycloheptane-1,2-diol hydrochloride, Mixture of diastereomers

  AD1635842470440-90-390%
• 

  4-methyl-1,4-diazepan-1-amine

  AD16353721091-66-790%
• 

  N-methylmorpholin-4-amine hydrochloride

  AD1634992247105-72-090%
• 

  1-amino-4-methyl-1,4lambda5-azaphosphinan-4-one

  AD1634892470439-41-790%
• 

  2-(morpholin-4-yl)ethyl carbonochloridate hydrochloride

  AD1631382742660-85-990%
• 

  2-(2,2,2-trifluoroethyl)piperazine

  AD162907910444-24-590%
• 

  3,3'-biazetidine dihydrochloride

  AD1627862416228-84-590%
• 

  2-amino-3-(methylsulfanyl)-1-(piperazin-1-yl)propan-1-one

  AD1627621541445-41-390%
• 

  rac-(3R,4R)-oxolane-3,4-diamine dihydrochloride, trans

  AD162734137279-45-990%
• 

  rac-2-({[(2R,5S)-5-{[(2-hydroxyethyl)amino]methyl}-1,4-dioxan-2-yl]methyl}amino)ethan-1-ol, trans

  AD1627322230789-88-390%
• 

  [(azetidin-2-yl)methyl](methyl)amine

  AD162725227030-58-290%
• 

  [(3S,5R)-3-(aminomethyl)-5-methylmorpholin-3-yl]methanol

  AD1626852219353-48-590%
• 

  azetidin-3-amine, bis(trifluoroacetic acid)

  AD1626622137786-35-590%
• 

  rac-(1R,2R)-cycloheptane-1,2-diamine dihydrochloride

  AD162656177765-50-390%
• 

  2-(piperazin-2-yl)ethan-1-ol hydrochloride

  AD1626221803606-94-190%
• 

  rac-(4aR,7aR)-6-[(tert-butoxy)carbonyl]-4,4-dioxo-hexahydro-2H-4lambda6-[1,4]oxathiino[2,3-c]pyrrole-7a-carboxylic acid, trans

  AD1621422694057-07-190%
• 

  lithium(1+) 3-ethoxyoxetane-3-carboxylate

  AD1620622694728-47-590%
• 

  2-{4-[(tert-butoxy)carbonyl]-5-(trifluoromethyl)morpholin-2-yl}acetic acid, Mixture of diastereomers

  AD1620372703780-87-290%
• 

  2-(1-methylcycloheptyl)acetic acid

  AD162006933695-47-790%